Lukáš Krásný

1.0k total citations
29 papers, 680 citations indexed

About

Lukáš Krásný is a scholar working on Molecular Biology, Spectroscopy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lukáš Krásný has authored 29 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Spectroscopy and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lukáš Krásný's work include Advanced Proteomics Techniques and Applications (11 papers), Mass Spectrometry Techniques and Applications (10 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Lukáš Krásný is often cited by papers focused on Advanced Proteomics Techniques and Applications (11 papers), Mass Spectrometry Techniques and Applications (10 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Lukáš Krásný collaborates with scholars based in United Kingdom, Czechia and United States. Lukáš Krásný's co-authors include Paul H. Huang, Igor Hochel, Radovan Hynek, Beatrice A. Howard, Patty T. Wai, Rachael Natrajan, Kateřina Demnerová, Vladimı́r Havlı́ček, Michael Volný and Martin Strohalm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Biochemical Journal.

In The Last Decade

Lukáš Krásný

28 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukáš Krásný United Kingdom 13 280 224 75 69 66 29 680
Gun Wook Park South Korea 15 715 2.6× 227 1.0× 70 0.9× 41 0.6× 54 0.8× 27 1.0k
Yuko Takahashi Japan 16 299 1.1× 50 0.2× 38 0.5× 57 0.8× 54 0.8× 34 648
Marco Fumagalli Italy 17 216 0.8× 70 0.3× 100 1.3× 36 0.5× 17 0.3× 43 573
Jean‐François Jacques Canada 16 831 3.0× 107 0.5× 28 0.4× 47 0.7× 52 0.8× 21 1.1k
Lichieh Julie Chu Taiwan 19 570 2.0× 78 0.3× 53 0.7× 60 0.9× 17 0.3× 51 915
Petra Hildebrandt Germany 19 389 1.4× 58 0.3× 62 0.8× 48 0.7× 22 0.3× 30 695
Khaja Muneeruddin United States 10 750 2.7× 163 0.7× 39 0.5× 44 0.6× 14 0.2× 14 957
Elisabet Carlsohn Sweden 10 409 1.5× 174 0.8× 12 0.2× 50 0.7× 13 0.2× 14 646
Shui‐Tsung Chen Taiwan 10 214 0.8× 80 0.4× 15 0.2× 72 1.0× 26 0.4× 11 491
Oliver Drews Germany 21 915 3.3× 227 1.0× 45 0.6× 200 2.9× 15 0.2× 43 1.4k

Countries citing papers authored by Lukáš Krásný

Since Specialization
Citations

This map shows the geographic impact of Lukáš Krásný's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukáš Krásný with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukáš Krásný more than expected).

Fields of papers citing papers by Lukáš Krásný

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukáš Krásný. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukáš Krásný. The network helps show where Lukáš Krásný may publish in the future.

Co-authorship network of co-authors of Lukáš Krásný

This figure shows the co-authorship network connecting the top 25 collaborators of Lukáš Krásný. A scholar is included among the top collaborators of Lukáš Krásný based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukáš Krásný. Lukáš Krásný is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Krásný, Lukáš, Jessica Burns, Emma Perkins, et al.. (2024). Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas. Clinical Cancer Research. 30(15). 3229–3242. 3 indexed citations
3.
Roy, Rajat K., Jennifer Doig, Lukáš Krásný, et al.. (2023). Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell Death and Disease. 14(11). 725–725. 6 indexed citations
4.
Ning, Jian, Lukáš Krásný, Amanda Swain, et al.. (2022). Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma. Cells. 11(15). 2418–2418. 1 indexed citations
5.
Krásný, Lukáš, Emma Perkins, Andrew Jenks, et al.. (2022). Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers. 14(12). 2907–2907. 3 indexed citations
6.
Krásný, Lukáš & Paul H. Huang. (2021). Advances in the proteomic profiling of the matrisome and adhesome. Expert Review of Proteomics. 18(9). 781–794. 20 indexed citations
7.
Milighetti, Martina, Lukáš Krásný, Yingtong Chen, et al.. (2021). Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry. Journal of Proteomics. 241. 104236–104236. 12 indexed citations
8.
Krásný, Lukáš & Paul H. Huang. (2020). Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Molecular Omics. 17(1). 29–42. 128 indexed citations
9.
Martínez, Víctor G., Lukáš Krásný, Tanya Singh, et al.. (2019). Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion. Cell Reports. 29(9). 2810–2822.e5. 66 indexed citations
10.
Krásný, Lukáš, et al.. (2018). Spatial localisation of Discoidin Domain Receptor 2 (DDR2) signalling is dependent on its collagen binding and kinase activity. Biochemical and Biophysical Research Communications. 501(1). 124–130. 3 indexed citations
11.
Krásný, Lukáš, Angela Paul, Patty T. Wai, et al.. (2016). Comparative proteomic assessment of matrisome enrichment methodologies. Biochemical Journal. 473(21). 3979–3995. 41 indexed citations
12.
Pól, Jaroslav, Lukáš Krásný, Michael Volný, et al.. (2015). Age-Related Changes in the Lateral Lipid Distribution in a Human Lens Described by Mass Spectrometry Imaging. European Journal of Mass Spectrometry. 21(3). 297–303. 8 indexed citations
13.
Krásný, Lukáš, et al.. (2014). Differentiation of Cronobacter spp. by tryptic digestion of the cell suspension followed by MALDI-TOF MS analysis. Journal of Microbiological Methods. 98. 105–113. 8 indexed citations
14.
Krásný, Lukáš, et al.. (2014). Lateral resolution in NALDI MSI: back to the future. Analytical and Bioanalytical Chemistry. 407(8). 2141–2147. 7 indexed citations
15.
Kuchař, Ladislav, Lukáš Krásný, Robert Dobrovolný, et al.. (2014). Fabry disease: renal sphingolipid distribution in the α-Gal A knockout mouse model by mass spectrometric and immunohistochemical imaging. Analytical and Bioanalytical Chemistry. 407(8). 2283–2291. 17 indexed citations
16.
Viktorová, Jitka, et al.. (2012). Osmotin, a Pathogenesis-Related Protein. Current Protein and Peptide Science. 13(7). 672–681. 37 indexed citations
17.
Hochel, Igor, et al.. (2012). Occurrence of Cronobacter spp. in retail foods. Journal of Applied Microbiology. 112(6). 1257–1265. 63 indexed citations
18.
Krásný, Lukáš, Martin Strohalm, Jean‐Philippe Bouchara, et al.. (2011). Scedosporium and Pseudallescheria low molecular weight metabolites revealed by database search. Mycoses. 54(s3). 37–42. 6 indexed citations
19.
Krásný, Lukáš, Radovan Hynek, & Milan Kodı́ček. (2011). Disulfide bond decay during matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry experiments. Rapid Communications in Mass Spectrometry. 25(17). 2468–2474. 3 indexed citations
20.
Strohalm, Martin, J. Strohalm, Filip Kaftan, et al.. (2011). Poly[N-(2-hydroxypropyl)methacrylamide]-Based Tissue-Embedding Medium Compatible with MALDI Mass Spectrometry Imaging Experiments. Analytical Chemistry. 83(13). 5458–5462. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026